XML 19 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash flows from operating activities:    
Net loss $ (11,808) $ (3,320)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 1 2
Noncash interest expense 123
Stock-based compensation 114 326
Warrants received as licensing fee (23)
Warrant modification expense 1,627
Change in fair value of equity investment 9 (4)
Common stock payable to consultant 566
Change in fair value of derivative liabilities 7,148
Gain on purchase of warrants (64)
Changes in operating assets and liabilities:    
Trade receivable (4) 8
Other accounts receivable and prepaid expenses (330) 107
Inventory (56) 12
Trade payables (82) (46)
Other accounts payable and accrued expenses (294) (19)
Deferred revenue 237 215
Accrued severance pay, net (2) (20)
Net cash used in operating activities (3,504) (2,073)
Cash flows from investing activities:    
Purchases of property plant and equipment (3)
Net cash used in investing activities (3)
Cash flows from financing activities:    
Proceeds from issuance of notes payable 42
Proceeds from note issued to related party 200
Payments of note payable to related party (200)
Proceeds from issuance of Preferred Series E stock 4,223
Proceeds from exercise of warrants 4,968
Buy back of warrants from investors (388)
Net cash provided by financing activities 4,580 4,265
Effects of currency translation on cash and cash equivalents (7)
Net increase in cash, cash equivalents and restricted cash 1,066 2,193
Cash, cash equivalents and restricted cash at beginning of period 7,533 1,338
Cash, cash equivalents and restricted cash at end of period 8,599 3,531
Supplemental non-cash financing and investing activities:    
Discount on notes payable 123
Issuance of common stock payable 566
Conversion of Series C, D, and E Preferred stock into common stock 1
Shares issued from exercise of warrants previously classified as derivative liability 2,087
Reclassification liability to equity due to increase in authorized shares $ 10,963